We are live on ! Find out more
NRS

Neville Rodie & Shaw Portfolio holdings

AUM $1.55B
1-Year Est. Return 46.95%
This Fund
S&P 500
This Quarter Est. Return
+3.75%
1 Year Est. Return
+46.95%
3 Year Est. Return
+114.59%
5 Year Est. Return
+149.24%
10 Year Est. Return
+498%
AUM
$948M
AUM Growth
+$41M
Cap. Flow
+$12.7M
Cap. Flow %
1.34%
Top 10 Hldgs %
27.51%
Holding
266
New
20
Increased
64
Reduced
83
Closed
5

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$8.88M
2
WAB icon
Wabtec
WAB
+$4.45M
3
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
+$2.26M
4
JPM icon
JPMorgan Chase
JPM
+$1.62M
5
XLRN
Acceleron Pharma
XLRN
+$1.57M

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$6.45M
2
WFC icon
Wells Fargo
WFC
+$1.74M
3
HSIC icon
Henry Schein
HSIC
+$1.42M
4
UPS icon
United Parcel Service
UPS
+$1.09M
5
CB icon
Chubb
CB
+$910K

Sector Composition

Rank Sector Weight
1 Healthcare 16.99%
2 Industrials 14.77%
3 Financials 14.58%
4 Technology 13.43%
5 Energy 11.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NRT
201
North European Oil Royalty Trust
NRT
$81M
$236K 0.02%
29,199
– –
CNC icon
202
Centene
CNC
$32.5B
$234K 0.02%
+3,800
New +$219K
ORI icon
203
Old Republic International
ORI
$10.4B
$233K 0.02%
11,720
– –
PEG icon
204
Public Service Enterprise Group
PEG
$37.7B
$232K 0.02%
4,284
– –
ACAD icon
205
Acadia Pharmaceuticals
ACAD
$5.03B
$229K 0.02%
+15,000
New +$267K
GIS icon
206
General Mills
GIS
$19.7B
$229K 0.02%
5,182
– –
HWC icon
207
Hancock Whitney
HWC
$6.24B
$226K 0.02%
4,850
– –
TRV icon
208
Travelers Companies
TRV
$80.2B
$226K 0.02%
1,850
– –
MMP
209
DELISTED
Magellan Midstream Partners, L.P.
MMP
$224K 0.02%
+3,250
New +$218K
AWK icon
210
American Water Works
AWK
$26.9B
$220K 0.02%
2,573
– –
INTU icon
211
Intuit
INTU
$89B
$218K 0.02%
+1,069
New +$205K
CDK
212
DELISTED
CDK Global, Inc.
CDK
$217K 0.02%
3,334
– –
NFLX icon
213
Netflix
NFLX
$309B
$215K 0.02%
+5,500
New +$187K
BLK icon
214
Blackrock
BLK
$176B
$212K 0.02%
425
– –
MER.PRK
215
Bank of America Income Capital Obligation Notes due December 15 2066
MER.PRK
$1.06B
$208K 0.02%
8,000
– –
SBUX icon
216
Starbucks
SBUX
$120B
$205K 0.02%
4,200
– –
BBT.PRE.CL
217
DELISTED
BB&T Corporation Depositary Shares each representing 1/1,000th interest in a share of Series E Non-C
BBT.PRE.CL
$204K 0.02%
8,000
– –
BKNG icon
218
Booking.com
BKNG
$161B
$203K 0.02%
2,500
– –
KHC icon
219
Kraft Heinz
KHC
$30B
$203K 0.02%
3,240
– –
GM icon
220
General Motors
GM
$76.8B
$201K 0.02%
+5,100
New +$201K
CVE icon
221
Cenovus Energy
CVE
$52.1B
$151K 0.02%
14,625
-3,920
-21% -$39.5K
HGT
222
DELISTED
Hugoton Royalty Trust
HGT
$11K ﹤0.01%
17,500
– –
MTNB icon
223
Matinas BioPharma
MTNB
$1.81M
$8K ﹤0.01%
+350
New +$10.1K
DXC icon
224
DXC Technology
DXC
$1.73B
– –
-2,817
Closed -$245K
HAL icon
225
Halliburton
HAL
$26.6B
– –
-4,395
Closed -$206K
6 7 8
9
10

Similar funds

BGCP
Bristol Gate Capital Partners Toronto, Ontario, Canada $1.55B AUM 12.75% 1-Year Est. Return
MSA
MUFG Securities Americas New York $1.55B AUM 28.4% 1-Year Est. Return
CET
Clean Energy Transition London, United Kingdom $1.54B AUM 34.41% 1-Year Est. Return
ICM
Irenic Capital Management New York $1.54B AUM 12.79% 1-Year Est. Return
CCM
Cinctive Capital Management New York $1.53B AUM 48.83% 1-Year Est. Return
TNBTD
Trustmark National Bank Trust Department Jackson, Mississippi $1.56B AUM 16.53% 1-Year Est. Return
MCP
Meridiem Capital Partners Dallas, Texas $1.53B AUM 17.03% 1-Year Est. Return
SG
Sienna Gestion Paris, France $1.53B AUM 27.73% 1-Year Est. Return

Neville Rodie & Shaw's Q2 2018 Portfolio in Review

As of Q2 2018, Neville Rodie & Shaw held 266 positions worth $948M, up 4.5% from $907M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Neville Rodie & Shaw's Q2 2018 filing shows 20 new, 64 increased, 83 reduced and 5 closed positions. Its largest new stake was Acceleron Pharma: 42,964 shares worth $2.08M. The largest sale was Invesco QQQ Trust, an estimated $6.45M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 17% a quarter earlier, followed by Industrials and Financials.

  • Neville Rodie & Shaw's largest Q2 2018 buy was Acceleron Pharma: 42,964 shares worth $2.08M.
  • Neville Rodie & Shaw added most to Allergan plc in Q2 2018, an estimated $8.88M increase.
  • Neville Rodie & Shaw's biggest Q2 2018 reduction was Wells Fargo, cutting an estimated $1.74M.
  • Neville Rodie & Shaw fully exited Invesco QQQ Trust in Q2 2018, selling an estimated $6.45M.
  • Neville Rodie & Shaw's ten largest holdings make up 28% of its $948M portfolio in Q2 2018.
  • Neville Rodie & Shaw opened 20 new positions and closed 5 in Q2 2018.
  • Neville Rodie & Shaw's portfolio value rose 4.5% quarter-over-quarter to $948M.

Based on Neville Rodie & Shaw's 13F filing for Q2 2018, filed 3 Jul 2018.